Diaba

Producto avalado por estudios clínicos

A new fructose-free, resistant-starch type IV-enriched enteral formula improves glycaemic control and cardiovascular risk biomarkers when administered for six weeks to elderly diabetic patients
Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized controlled trial
Diaba

Dieta completa normoproteica y normocalórica con mezcla de fibras